MXPA06000636A - Formulaciones semi-solidas para la administracion oral de taxoides. - Google Patents

Formulaciones semi-solidas para la administracion oral de taxoides.

Info

Publication number
MXPA06000636A
MXPA06000636A MXPA06000636A MXPA06000636A MXPA06000636A MX PA06000636 A MXPA06000636 A MX PA06000636A MX PA06000636 A MXPA06000636 A MX PA06000636A MX PA06000636 A MXPA06000636 A MX PA06000636A MX PA06000636 A MXPA06000636 A MX PA06000636A
Authority
MX
Mexico
Prior art keywords
taxoids
oral administration
semi
solid formulations
formulations
Prior art date
Application number
MXPA06000636A
Other languages
English (en)
Inventor
Carole Neves
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MXPA06000636A publication Critical patent/MXPA06000636A/es
Publication of MX260260B publication Critical patent/MX260260B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Formulaciones semi-solidas para la administracion oral de taxoides .La presente invencion se refiere a nuevas formulaciones de taxoides para administracion oral.
MXPA06000636 2003-07-18 2004-07-15 Formulaciones semi-solidas para la administracion oral de taxoides. MX260260B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03291795A EP1498120A1 (en) 2003-07-18 2003-07-18 Semi-solid formulations for the oral administration of taxoids
PCT/EP2004/008551 WO2005013968A1 (en) 2003-07-18 2004-07-15 Semi-solid formulations for the oral administration of taxoids

Publications (2)

Publication Number Publication Date
MXPA06000636A true MXPA06000636A (es) 2006-04-19
MX260260B MX260260B (es) 2008-09-04

Family

ID=33462258

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06000636 MX260260B (es) 2003-07-18 2004-07-15 Formulaciones semi-solidas para la administracion oral de taxoides.

Country Status (21)

Country Link
US (1) US20050070496A1 (es)
EP (2) EP1498120A1 (es)
JP (1) JP5116306B2 (es)
KR (1) KR101143341B1 (es)
CN (1) CN1826110B (es)
AR (1) AR045996A1 (es)
AT (1) ATE388701T1 (es)
AU (1) AU2004262496B2 (es)
BR (1) BRPI0412759A (es)
CA (1) CA2532667A1 (es)
DE (1) DE602004012413T2 (es)
DK (1) DK1648440T3 (es)
ES (1) ES2303642T3 (es)
HK (1) HK1091743A1 (es)
IL (1) IL173110A (es)
IN (1) IN229997B (es)
MX (1) MX260260B (es)
MY (1) MY137965A (es)
PT (1) PT1648440E (es)
TW (1) TWI342774B (es)
WO (1) WO2005013968A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498143A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
JP2009538317A (ja) * 2006-05-26 2009-11-05 バイエル ヘルスケア リミティド ライアビリティ カンパニー 癌治療のための置換ジアリールウレアを用いた薬物の組み合わせ
FR2922107B1 (fr) * 2007-10-10 2010-02-26 Aventis Pharma Sa Nouvelles compositions a base de taxoides
FR2924024B1 (fr) 2007-11-27 2012-08-17 Centre Nat Rech Scient Nanoparticules d'actifs therapeutiques de faible solubilite aqueuse
FR2931152B1 (fr) * 2008-05-16 2010-07-30 Centre Nat Rech Scient Nouveau systeme de transfert d'acide nucleique
BR112012011457A2 (pt) 2009-10-29 2016-05-03 Aventis Pharma Sa uso antitumoral de cabazitaxel.
CN102970990A (zh) 2010-05-03 2013-03-13 帝国制药美国公司 非水性紫杉烷前-乳剂制剂以及制备和使用该制剂的方法
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN103980232A (zh) * 2014-06-05 2014-08-13 北京诺普德医药科技有限公司 10-乙酰基多西紫杉醇及其用途
KR101542364B1 (ko) * 2014-10-31 2015-08-07 대화제약 주식회사 탁산을 포함하는 경구 투여용 약학 조성물
CN113698369A (zh) * 2021-08-31 2021-11-26 无锡紫杉药业有限公司 一种除去卡巴他赛中特定单杂的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3406497A1 (de) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner Hochdisperse pharmazeutische mehrkomponentensysteme und verfahren zu ihrer herstellung
US5272171A (en) * 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
US5294637A (en) * 1992-07-01 1994-03-15 Bristol-Myers Squibb Company Fluoro taxols
JP3208517B2 (ja) * 1992-07-01 2001-09-17 ブリストル−マイヤーズ スクイブ カンパニー ７，８−シクロプロパタキサン類
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
US5478854A (en) * 1992-10-01 1995-12-26 Bristol-Myers Squibb Company Deoxy taxols
US5973160A (en) * 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
US5646176A (en) * 1992-12-24 1997-07-08 Bristol-Myers Squibb Company Phosphonooxymethyl ethers of taxane derivatives
US6054136A (en) * 1993-09-30 2000-04-25 Gattefosse S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
IL131217A0 (en) * 1998-03-10 2001-01-28 Napro Biotherapeutics Inc Novel methods and compositions for delivery of taxanes
CA2326485C (en) * 1998-04-01 2008-12-09 Rtp Pharma Inc. Anticancer compositions
JP2003500368A (ja) * 1999-05-24 2003-01-07 ソーナス ファーマシューティカルス，インコーポレイテッド 溶解度が不十分な薬剤のためのエマルジョンビヒクル
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
MXPA03006404A (es) * 2001-01-18 2004-12-02 Upjohn Co Composiciones quimioterapeuticas de microemulsion de paclitaxel con biodisponibilidad oral mejorada.
US20040092428A1 (en) * 2001-11-27 2004-05-13 Hongming Chen Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
KR20040066921A (ko) * 2001-12-20 2004-07-27 브리스톨-마이어스스퀴브컴파니 생체이용률이 향상된 경구 활성 탁산 유도체의 제약조성물
ATE359779T1 (de) * 2002-03-01 2007-05-15 Novagali Pharma Sa Selbstemulgierende systeme zur abgabe von taxoiden
KR20090072980A (ko) * 2007-12-28 2009-07-02 서울옵토디바이스주식회사 발광 다이오드 및 그 제조방법

Also Published As

Publication number Publication date
ES2303642T3 (es) 2008-08-16
DK1648440T3 (da) 2008-07-14
IL173110A (en) 2011-04-28
MY137965A (en) 2009-04-30
CN1826110A (zh) 2006-08-30
AU2004262496A1 (en) 2005-02-17
BRPI0412759A (pt) 2006-09-26
JP5116306B2 (ja) 2013-01-09
CN1826110B (zh) 2010-05-12
ATE388701T1 (de) 2008-03-15
KR101143341B1 (ko) 2012-05-24
EP1648440A1 (en) 2006-04-26
US20050070496A1 (en) 2005-03-31
DE602004012413T2 (de) 2009-03-12
EP1498120A1 (en) 2005-01-19
PT1648440E (pt) 2008-06-24
KR20060037370A (ko) 2006-05-03
EP1648440B1 (en) 2008-03-12
HK1091743A1 (en) 2007-01-26
MX260260B (es) 2008-09-04
IN229997B (es) 2009-03-27
CA2532667A1 (en) 2005-02-17
DE602004012413D1 (de) 2008-04-24
JP2009513558A (ja) 2009-04-02
IN2006CH00198A (es) 2007-06-08
AU2004262496B2 (en) 2009-02-05
TWI342774B (en) 2011-06-01
WO2005013968A1 (en) 2005-02-17
AR045996A1 (es) 2005-11-23
TW200517104A (en) 2005-06-01
IL173110A0 (en) 2006-06-11

Similar Documents

Publication Publication Date Title
HK1076605A1 (en) Formulations
HUS1800013I1 (hu) Cladribine tartalmú orális gyógyászati készítmény
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
TNSN06012A1 (en) Emulsifying systems containing azetidine derivatives
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
HK1091743A1 (en) Semi-solid formulations for the oral administration of taxoids
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
UA86591C2 (ru) Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
BR0207640A (pt) Composição farmacêutica oral de cefpodoxima proxetil
BRPI0408895A (pt) formulações de cladribina para administração oral e transmucosal aperfeiçoada
ZA200604874B (en) Pharmaceutical compositions
MY139106A (en) Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
TNSN06013A1 (en) Semi-solid systems containing azetidine derivatives
SE0200657D0 (sv) Novel Formulation
TW200603801A (en) Novel dialkoxy-imidazopyridines
TW200613301A (en) Novel amino-halogen-imidazopyridines
TW200504075A (en) Imidazopyridine intermediates
EA200601842A1 (ru) D-гомо-17-хлор-16(17)-ен-стероиды

Legal Events

Date Code Title Description
FG Grant or registration